On December 17, 2025, the Centers for Disease Control and Prevention (CDC) announced the formal end of its recommendation for hepatitis B vaccinations for all newborns. This decision marks a significant change in public health policy regarding the vaccination of infants against hepatitis B, a viral infection that can lead to serious liver disease.
The CDC"s updated guidance reflects a shift in the agency"s approach to vaccination protocols for newborns. The specifics of the rationale behind this decision have not been disclosed in the announcement.
This development comes amid ongoing discussions about vaccination policies and public health strategies. For more information on related topics, see recent developments in global health initiatives.
The CDC"s decision will likely prompt further examination and discussion among healthcare professionals and policymakers regarding the implications for newborn health and vaccination practices.

Image for CDC ends recommendation for hepatitis B vaccines for all newborns






